Single-cell transcriptomics of the ocular anterior segment: a comprehensive review

Eye (Lond). 2023 Nov;37(16):3334-3350. doi: 10.1038/s41433-023-02539-3. Epub 2023 May 3.

Abstract

Elucidating the cellular and genetic composition of ocular tissues is essential for uncovering the pathophysiology of ocular diseases. Since the introduction of single-cell RNA sequencing (scRNA-seq) in 2009, vision researchers have performed extensive single-cell analyses to better understand transcriptome complexity and heterogeneity of ocular structures. This technology has revolutionized our ability to identify rare cell populations and to make cross-species comparisons of gene expression in both steady state and disease conditions. Importantly, single-cell transcriptomic analyses have enabled the identification of cell-type specific gene markers and signalling pathways between ocular cell populations. While most scRNA-seq studies have been conducted on retinal tissues, large-scale transcriptomic atlases pertaining to the ocular anterior segment have also been constructed in the past three years. This timely review provides vision researchers with an overview of scRNA-seq experimental design, technical limitations, and clinical applications in a variety of anterior segment-related ocular pathologies. We review open-access anterior segment-related scRNA-seq datasets and illustrate how scRNA-seq can be an indispensable tool for the development of targeted therapeutics.

摘要: 阐明眼组织细胞和基因的组成对于明确眼病的病理生理学是至关重要的。自从2009年单细胞RNA测序 (scRNA-seq) 引进以来, 视觉研究人员为了来更好理解眼部结构转录组的复杂性和异质性, 进行了深入的单细胞组学研究。这项技术彻底改变了我们辨别稀有细胞群及在稳态和病态条件下对基因表达进行跨物种比较的能力。重要的是, 单细胞转录组分析使我们能在眼细胞群之间识别细胞类型的特殊的基因标记物以及信号通路。虽然大部分scRNA-seq用于视网膜组织研究, 但在过去三年中也设计了大规模眼前节转录组图谱。这篇适时的综述为视觉研究人员针对不同眼前节相关眼病提供了scRNA-seq实验设计、技术限制和临床应用的概述。我们回顾了眼前节相关scRNA-scq的公开的公开数据集, 并解释scRNA-seq为何是靶向治疗不可或缺的工具。.

Publication types

  • Review

MeSH terms

  • Gene Expression Profiling*
  • Humans
  • Sequence Analysis, RNA
  • Signal Transduction
  • Single-Cell Analysis
  • Transcriptome*